News|Articles|August 21, 2026

NeurologyLive® Friday 5 — August 21, 2026

Listen
0:00 / 0:00

Key Takeaways

  • Concussion management increasingly emphasizes individualized assessment, evolving diagnostic approaches, and tailored rehabilitation amid persistent clinical challenges.
  • FDA agreement on ATH434’s Phase 3 program defines a clearer development route for a potential disease-modifying therapy in multiple system atrophy.
SHOW MORE

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 21, 2026.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Exploring the Evolving Approach to Concussion Care

In a recent Q&A interview, Kyle Marden, MD, sports neurologist and medical director of the Concussion and Sports Neurology Program at Northwestern Medicine, discusses emerging developments in concussion diagnosis and management, ongoing challenges in the field, and the future of individualized care.

2: ATH434's Phase 3 Path Is Set: Alterity on What FDA Alignment Means for MSA

In a recent Q&A interview, David Stamler, MD, Chief Executive Officer of Alterity Therapeutics, discusses the FDA's alignment on the pivotal Phase 3 program for ATH434 in multiple system atrophy and what a successful trial could mean for a disease with no approved disease-modifying therapies.

3: Evolving Dieting Strategies Address New Challenges in SMA Care

In a recent Q&A interview, Stacey Tarrant, RD, LDN, a dietitian at Boston Children’s Hospital, discusses how earlier treatment alongside disease-modifying therapies have changed nutritional priorities in spinal muscular atrophy, including the need to optimize growth, strength, function, and body composition.

4: NeuroVoices: Young Lee, MD, on Applying Newly FDA Cleared THUNDERBOLT Stroke Thrombectomy

In our latest NeuroVoices Q&A, Young Lee, MD, cerebrovascular neurosurgeon at University Medical Center New Orleans, discussed performing the first THUNDERBOLT stroke thrombectomy in the United States and what computer-assisted vacuum thrombectomy offers over traditional aspiration.

5: Why Effective Care in SMA Requires More Than a Neurologist: W. Bryan Burnette, MD

In a recent video interview, W. Bryan Burnette, MD, chief of neurology at Nemours Children’s Health, outlined the specialties that may be essential to comprehensive care for patients with spinal muscular atrophy. [WATCH TIME: 5 minutes]

Which conversation stood out most to you in this week’s NeurologyLive Friday Five?

Q&A: Kyle Marden, MD
Q&A: David Stamler, MD
Q&A: Stacey Tarrant, RD, LDN
Q&A: Young Lee, MD
Video: W. Bryan Burnette, MD

Don’t have time to read or watch a full video interview? Click here to check out our shorts!


Latest CME